KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Non-Current Deferred Tax Liability (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Non-Current Deferred Tax Liability readings, the most recent being $273.0 million for Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 40.78% to $273.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $273.0 million, a 40.78% decrease, with the full-year FY2025 number at $296.0 million, down 38.72% from a year prior.
  • Non-Current Deferred Tax Liability hit $273.0 million in Q1 2026 for Teva Pharmaceutical Industries, down from $296.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $666.0 million in Q1 2022 to a low of $273.0 million in Q1 2026.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $534.0 million (2023), compared with a mean of $499.7 million.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: tumbled 44.73% in 2022 and later increased 10.58% in 2023.
  • Teva Pharmaceutical Industries' Non-Current Deferred Tax Liability stood at $548.0 million in 2022, then rose by 10.58% to $606.0 million in 2023, then fell by 20.3% to $483.0 million in 2024, then plummeted by 38.72% to $296.0 million in 2025, then decreased by 7.77% to $273.0 million in 2026.
  • The last three reported values for Non-Current Deferred Tax Liability were $273.0 million (Q1 2026), $296.0 million (Q4 2025), and $399.0 million (Q3 2025) per Business Quant data.